Clinical Trials Directory

Trials / Completed

CompletedNCT01591226

Caffeine and Sodium Citrate Ingestion

Effects of Caffeine and Sodium Citrate Ingestion in 1500m Wheelchair Racing Athletes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
Swiss Paraplegic Research, Nottwil · Network
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

A positive ergogenic effect of sodium citrate and caffeine ingestion in a short-term, high-intensity exercise task was shown by several studies. These studies were conducted with healthy, able-bodied subjects. The aim of the study is to investigate whether caffeine or sodium citrate ingestion could enhance performance in spinal cord injured wheelchair athletes. It is a double blind, placebo controlled and randomized study.

Detailed description

The athletes have to complete four 1500m tests on a training roller. Before each treatment they get different supplementations. Once they get sodium citrate and a placebo, once caffeine and a placebo, once sodium citrate and caffeine and for the fourth treatment they get twice a placebo. Two hours after starting with the supplementation they have to complete the 1500m as fast as possible. Time to complete 1500m, blood pH, plasma bicarbonate, sodium concentration, heart rate, oxygen consumption, blood lactate concentration and rate of perceived exertion (RPE) were measured.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCaffeinegelatine capsule 6mg/kg bodyweight 60min prior test
DIETARY_SUPPLEMENTSodium Citrate0.5g/kg bodyweight diluted in 7dl water ingested 120-90min prior test
DIETARY_SUPPLEMENTMannitolgelatine capsule filled with mannitol (100mg per capsule) ingested 60min prior test
DIETARY_SUPPLEMENTSodium Chloridesodium chloride diluted in 7dl water 0.045g/kg bodyweight 120-90min prior test

Timeline

Start date
2012-02-01
Primary completion
2012-09-01
Completion
2012-09-01
First posted
2012-05-03
Last updated
2016-11-22

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT01591226. Inclusion in this directory is not an endorsement.